Prior Seminar Recordings

Fall 2022

Randy J. Seeley, Ph.D.
(U. Michigan)

“What bariatric surgery tells us about the role the gut plays in the
regulation of metabolism”

Jeffrey E. Pessin, PhD
(Albert Einstein College of Medicine)

“Temporal and spatial cellular heterogeneity of hepatocyte metabolism”

Spring 2022

David B. Allison, PhD

“Obesity and Mortality”

Ian de Boer, MD, MS
(U Wash)

“Progress in Diabetic Kidney Disease”

Josiemer Mattei, PhD

“Food, culture, and health in Hispanics/Latinx: from evidence to action”

Silvia Corvera, MD

“Thermogenic adipose tissue and metabolic disease”

Maureen Gannon, PhD

“Intersection of prostagladin E2 and GLP-1 signaling pathways to promote beta-cell identity, proliferation, survival”

Hilary Seligman, PhD

“Diabetes and the Food is Medicine Movement: 2022 Updates”

Spring 2021

Felicia Hill-Briggs, PhD, ABPP
(Johns Hopkins)

“Social Determinants of Health and Diabetes: Focusing a Newer Lens”

E. Dale Abel, MD, PhD
(U. Iowa)

“Diabetes and Heart Failure – Mitochondrial Mechanisms”

Debbie Thurmond,
(City of Hope)

“Insulin secretion and peripheral Insulin action:
orchestrating better harmony”

William Parker, MD, MS

Monica Peek, MD, MPH, MS, FACP

Kamlesh Khunti, MD, PhD, FRCP, FRCGP, FMedSci

COVID-19 Panel Discussion

Jose Florez, MD, PhD (Harvard)

“Clinical Translation of Genetic Predictors for Type 2 Diabetes”

Darleen Sandoval, PhD (Univ. Colorado)

“Lessons from mouse models of bariatric surgery”

Carmella Evans-Molina, MD, PhD

Peter Jackson, PhD

Shuibing Chen, PhD

“COVID and Diabetes Panel”

Jaclynn Hawkins, PhD
(Univ. Michigan)

“Type 2 Diabetes in African American Men: Lessons Learned and the Road Ahead”

Fall 2021

Peter Turnbaugh, PhD (UCSF)

Ruth Ley, PhD (Cornell)

“Diabetes and the Gut Microbiota”

Rebecca Hull-Meichle, PhD

“Impact of Exocrine Pancreas Pathology on Islet Function and Survival”

David D’Alessio, MD

“GLP-1RA physiology and pharmacology”

Thomas W. Gardner, MD, MS
(U. Michigan)

S. Robert Levine, MD
(The Mary Tyler Moore & S. Robert Levine, MD Charitable Foundation)

“It is Time for a Moonshot for Diabetic Retinal Disease”

Spring 2020

Dr. Steven Kahn, MB, ChB
(University of Washington)

“Unraveling Beta-cell Dysfunction in Type 2 Diabetes: From the Unpredicted to the Unknown”

Victor L. Schuster, M.D.
(Albert Einstein College of Medicine)

“To burn, or not to burn: fat is the question”

Anath Shalev, MD

“Preservation of islet function in type 1 diabetes – from bench to bedside”

Carey N. Lumeng, MD, PhD
(University of Michigan)

“Adipose tissue macrophage function in diabetes and obesity”

Nancy Cox, PhD
(Vanderbilt University)

“Working toward a translation of polygenic liability”

William Herman, MD, MPH
(University of Michigan)

“Closing the Gap: Diabetes Prevention and Treatment – Take 2”

Michael Weiss, MD, PhD, MBA
(Indiana University)

“Adventures with Insulin: From Structural Biology to Novel Therapeutics”

Lindsay Mayberry, PhD
(Vanderbilt University)

“Leveraging Family and Social Contexts to Sustain Diabetes Self-care Behavior Change”

Don McClain, MD, PhD
(Wake Forest)

“Diabetes and Iron: Can’t Live With It, Can’t Live Without It”

Seung Kim, MD, PhD

“Alpha cell and glucagon regulation in development and diabetes”

Jane Reusch, MD

“Microvascular Contributions to Exercise Intolerance in Diabetes”

Jeffrey Gonzalez, PhD
(Albert Einstein College of Medicine)

“Tangled Up In Blue: Depression, Distress and Diabetes”

Fall 2020

Anna Gloyn, DPhil

“Using human genetics to unravel mechanisms of human islet-cell dysfunction in type 2 diabetes”

Spero Manson, PhD
(U. Colorado)

“Behavioral Health Problems and Diabetes: Risk, Prevention, and Management Among Native Peoples”

Karin Bornfeldt, PhD
(U. Washington)

“A human-first approach to identify mechanisms of cardiovascular complications of diabetes”